Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudy.
暂无分享,去创建一个
E. Antman | E. Braunwald | C. Cannon | S. Murphy | J. D. de Lemos | C. Gibson | M. Tanasijevic | H. Mueller | M. Greenberg | V. Srinivas | S. Sokol | C. Gibson
[1] F Van de Werf,et al. Cost effectiveness of early discharge after uncomplicated acute myocardial infarction. , 2000, The New England journal of medicine.
[2] C M Gibson,et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. , 2000, Circulation.
[3] E. Antman,et al. Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B. , 1999, Journal of the American College of Cardiology.
[4] R. Califf,et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.
[5] R. Giugliano,et al. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators. , 1998, Circulation.
[6] K. Lee,et al. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. , 1998, Circulation.
[7] P O Collinson,et al. Troponin T or troponin I or CK-MB (or none?). , 1998, European heart journal.
[8] R. CANEPA-ANSON,et al. Troponin T measurement after myocardial infarction can identify left ventricular ejection of less than 40% , 1998, Heart.
[9] M. Plebani,et al. Diagnostic strategies in myocardial infarction using myoglobin measurement. , 1998, European heart journal.
[10] E. Antman,et al. Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: results from TIMI 10A. , 1997, American heart journal.
[11] Richard P. Lewis,et al. ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction , 1996 .
[12] F. Harrell,et al. Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia , 1996 .
[13] D Wybenga,et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. , 1996, The New England journal of medicine.
[14] J Col,et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. , 1995, Circulation.
[15] C. Bode,et al. Assessment of reperfusion of the infarct zone after acute myocardial infarction by serial cardiac troponin T measurements in serum. , 1994, British heart journal.
[16] H. Katus,et al. The prognostic value of serum troponin T in unstable angina. , 1992, The New England journal of medicine.
[17] E. Braunwald,et al. Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. The Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-Investigators. , 1990, Journal of the American College of Cardiology.
[18] H. S. Mueller,et al. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.